Agenus Inc. (AGEN)
NASDAQ: AGEN · Real-Time Price · USD
6.40
+0.19 (3.06%)
At close: Nov 18, 2026, 4:00 PM EST
6.50
+0.10 (1.56%)
After-hours: Nov 18, 2026, 7:30 PM EST
Agenus Market Cap
Agenus has a market cap or net worth of $289.58 million as of November 18, 2026. It is the 18,152nd most valuable company in the world and the 3,203rd biggest in the United States. Its market cap has increased by 97.13% in one year.
Market Cap
289.58M
Enterprise Value
242.11M
1-Year Change
97.13%
Global Rank
Country Rank
#3,203 United States
Category
ChartMarket Cap Chart
Since February 8, 2000, Agenus's market cap has decreased from $1.10B to $289.58M, a decrease of -73.60%. That is a compound annual growth rate of -4.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 289.58M | 171.14% |
| Dec 31, 2025 | 106.80M | 66.10% |
| Dec 31, 2024 | 64.30M | -79.64% |
| Dec 29, 2023 | 315.80M | -56.83% |
| Dec 30, 2022 | 731.50M | -11.55% |
| Dec 31, 2021 | 827.00M | 36.76% |
| Dec 31, 2020 | 604.70M | 8.16% |
| Dec 31, 2019 | 559.10M | 95.76% |
| Dec 31, 2018 | 285.60M | -12.55% |
| Dec 29, 2017 | 326.60M | -9.03% |
| Dec 30, 2016 | 359.00M | -6.58% |
| Dec 31, 2015 | 384.30M | 54.40% |
| Dec 31, 2014 | 248.90M | 165.92% |
| Dec 31, 2013 | 93.60M | -7.14% |
| Dec 31, 2012 | 100.80M | 134.97% |
| Dec 30, 2011 | 42.90M | -57.23% |
| Dec 31, 2010 | 100.30M | 74.74% |
| Dec 31, 2009 | 57.40M | 80.50% |
| Dec 31, 2008 | 31.80M | -67.22% |
| Dec 31, 2007 | 97.00M | 15.61% |
| Dec 29, 2006 | 83.90M | -61.34% |
| Dec 30, 2005 | 217.00M | -52.90% |
| Dec 31, 2004 | 460.70M | 2.90% |
| Dec 31, 2003 | 447.70M | 32.18% |
| Dec 31, 2002 | 338.70M | -28.80% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scribe Therapeutics | 287.28M |
| Editas Medicine | 287.07M |
| Fulcrum Therapeutics | 284.14M |
| TRex Bio | 282.55M |
| Inovio Pharmaceuticals | 278.45M |
| Century Therapeutics | 277.84M |
| AgomAb Therapeutics NV | 277.76M |
| Eikon Therapeutics | 275.81M |